第1病理学 研究業績

最近の研究業績（2018年～2023年の主な発表論文等）

・Iwamura R, Komatsu K, Kusano M, Kubo C, Inaba Y, Shiba E, Nawata A, Tajiri R, Matsuyama A, Matoba H, Koga K, Takeda M, Itami H, Hisaoka M. PDGFRB and NOTCH3 Mutations are Detectable in a Wider Range of Pericytic Tumors, Including Myopericytomas, Angioleiomyomas, Glomus Tumors, and Their Combined Tumors. Mod Pathol. 36(3): 2023

・柴　瑛介．【壊死性筋膜炎】, 【滑膜肉腫】, 【未分化多形肉腫】, 病理診断クイックリファレンス2023．病理と臨床 41: 262, 269, 271,  2023

・Nawata A, Shirayama R, Oshida K, Sato T, Ito T, Shiba E, Kusuhara K, Hisaoka M. Catastrophic antiphospholipid syndrome with Epstein-Barr virus-associated hemophagocytosis: A clinicopathological conference. Lupus. 31(11): 1385-1393, 2022.

・Nawata A, Iwamura R, Shiba E, Inaba Y, Kubo C, Kusano M, Komatsu K, Tanaka Y, Hisaoka M. Light chain proximal tubulopathy after improvement of tubulointerstitial nephritis in Sjögren's syndrome. Pathol Int. 72(10): 525-527, 2022.

・名和田　彩. ループス腎炎・膠原病関連腎症-血管炎を除く-. 「非腫瘍性疾患病理アトラス　腎」 文光堂 (2022).

・Tajiri R, Shiba E, Iwamura R, Kubo C, Nawata A, Harada H, Yoshino K, Hisaoka M. Potential pathogenetic link between angiomyofibroblastoma and superficial myofibroblastoma in the female lower genital tract based on a novel MTG1-CYP2E1 fusion. Mod Pathol. 34(12): 2222-2228, 2021

・Tsuda Y, Matsuyama A, Makihara K, Higaki K, Motoi T, Okuma T, Hisaoka M. Nuclear expression of MDM2 in hibernoma: a potential diagnostic pitfall. Virchows Arch. 478(3): 527-534, 2021

・Nawata A, Yamaguchi Y, Otsu K, Satake M, Matsuki Y. Small intestinal xanthomatosis leading to dysmotility. Pathol Int. 71(4): 287-289, 2021.

・Nawata A, Nakamura A, Taba M, Kosaka S, Kawabe A, Miyata H, Matsuki Y, Tanaka Y, Hisaoka M. Fatal hemoperitoneum due to rupture of mesenteric artery in remission state of microscopic polyangiitis, concomitant with severe hypertension and posterior reversible encephalopathy syndrome: an autopsy case report. CEN Case Rep. 10(4):549-558, 2021.

・Nawata A, Izumi R, Harada K, Kurisu H, Shimajiri S, Matsuki Y, Nakayama T. An elderly-onset neuroblastoma concomitant with minimal change nephrotic syndrome: the first autopsy case report. CEN Case Rep. 10(3): 414-421, 2021.

・柴　瑛介、久岡　正典. 精管および精巣付属器の間葉系腫瘍. 「精巣腫瘍病理アトラス」 文光堂 (2021).

・Yabuki K, Haratake J, Hisaoka M. Lanthanum deposition in the gastroduodenal mucosa of dialysis patients. J UOEH. 41(4): 387-395, 2019

・Matsuyama A, Jotatsu M, Uchihashi K, Tsuda Y, Shiba E, Haratake J, Hisaoka M. MUC4 expression in meningiomas: under-recognized immunophenotype particularly in meningothelial and angiomatous subtypes. Histopathology. 74(2): 276-283, 2019

・Harada H, Tsuda Y, Yabuki K, Shiba E, Uchihashi K, Matsuyama A, Fujino Y, Hachisuga T, Hisaoka M. Inhibition of WNT/β-catenin signaling under serum starvation and hypoxia induces adipocytic transdifferentiation in human leiomyoma cells. Lab Invest. 98(4): 439-448, 2018

・Yabuki K, Haratake J, Tsuda Y, Shiba E, Harada H, Yorita K, Uchihashi K, Matsuyama A, Hirata K, Hisaoka M. Lanthanum-induced mucosal alterations in the stomach (lanthanum gastropathy): a comparative study using an animal model. Biol Trace Elem Res. 185(1): 36-47, 2018

・Yabuki K, Matsuyama A, Shiba E, Nagatani G, Hisaoka M. Sclerosing Mucoepidermoid Carcinoma in the Parotid Gland With CRTC1-MAML2 Fusion: A Case Report. Int J Surg Pathol. 26(3): 250-255, 2018

これまでの研究業績（2017年以前の主な発表論文）

・Matsuyama A, Shiba E, Umekita Y, Nosaka K, Kamio T, Yanai H, Miyasaka C, Watanabe R, Ito I, Tamaki T, Hayashi S, Hisaoka M. Clinicopathologic Diversity of Undifferentiated Sarcoma With BCOR-CCNB3 Fusion: Analysis of 11 Cases With a Reappraisal of the Utility of Immunohistochemistry for BCOR and CCNB3. Am J Surg Pathol. 41(12): 1713-1721, 2017.

・Uchihashi K, Matsuyama A, Shiba E, Kimura Y, Ogata T, Yabuki K, Harada H, Kubo C, Tsuda Y, Jotatsu M, Hisaoka M. Retroperitoneal dedifferentiated liposarcoma with huge cystic degeneration: A case report. Pathol Int. 67(5): 264-268, 2017.

・柴瑛介、澁谷亮、矢吹慶、原田大史、内橋和芳、松山篤二、岡田和将、久岡正典. 低ガンマグロブリン血症を背景に発症した進行性多巣性白質脳症の1例. 診断病理 34(1): 19-23, 2017.

・Yabuki K, Shiba E, Harada H, Uchihashi K, Matsuyama A, Haratake J, Hisaoka M.Lanthanum deposition in the gastrointestinal mucosa and regional lymph nodes in dialysis patients: Analysis of surgically excised specimens and review of the literature. Pathol Res Pract. 212(10): 919-926, 2016.

・Uchihashi K, Matsuyama A, Nakayama M, Sakamoto A, Shiba E, Hisaoka M. Myxoid liposarcoma with pleomorphic cells: Report of two cases with molecular confirmation of FUS gene rearrangements. Pathol Res Pract. 212(11): 1067-1070, 2016.

・Nakamoto M, Hisaoka M. Clinicopathological Implications of Wingless/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma. J UOEH 38(1): 1-8, 2016.

・Shiba E, Matsuyama A, Shibuya R, Yabuki K, Harada H, Nakamoto M, Kasai T, Hisaoka M. Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant. Diagn Pathol 11(1): 26, 2016.

・矢吹慶、柴瑛介、澁谷亮、原田大史、松山篤二、安田浩、久岡正典．原発性リンパ浮腫の1例．診断病理　32(4): 312－316, 2015

・Shibuya R, Matsuyama A, Shiba E, Harada H, Yabuki K, Hisaoka M. CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Histopathology 67(12): 827-835, 2015.

・Shibuya R, Matsuyama A, Nakamot M, Shiba E, Kasai T, Hisaoka M. The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma. Virchows Arch 465 (5): 599-605, 2014.

・Nakamoto M, Matsuyama A, Shiba E, Shibuya R, Kasai T, Yamaguchi K, Hisaoka M. Prognostic significane of WNT signaling in pancreatic ductal adenocarcinoma. Virchows Arch 465 (4): 401-408, 2014.

・Hisaoka M. Lipoblasts: morphologic features and diagnostic value. J UOEH 36(2):115-121, 2014

・松山篤二、久岡正典．【WHO 2013分類に基づく骨・軟部腫瘍の画像診断】　軟部腫瘍の基本的な概念と組織像に基づく分類． 臨床画像: 704-712, 2014

・松山篤二、久岡正典．【免疫組織化学　診断と治療選択の指針】（第2部）腫瘍の鑑別に用いられる抗体（各臓器別）軟部． 病理と臨床 32臨増: 268-273, 2014

・澁谷亮、久岡正典．【皮膚疾患のみかたII-腫瘍および腫瘍様病変-】神経系腫瘍．病理と臨床 32: 378-382, 2014

・Hisaoka M, Matsuyama A, Aoki T, Sakamoto A, Yokoyama K. Low-grade fibromyxoid sarcoma with prominent giant rosettes and heterotopic ossification. Pathol Res Pract. 208: 557-60, 2012

・Hisaoka M, Matsuyama A, Nakamoto M. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma. Am J Pathol. 180: 2076-83, 2012

・Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma. Mod Pathol. 25: 112-21, 2012

・久岡正典、澁谷亮． Ewing肉腫について -新たなバイオマーカーを利用した腫瘍診断-．病理と臨床 32: 161-165, 2014

・Kubota F, Matsuyama A, Shibuya R, Nakamoto M, Hisaoka M, Desmin-positivity in spindle cells: under-recognized immuophenotype of lipoblastoma. Pathol Int. 63: 353-7, 2013

・Matsuyama A, Hisaoka M, Hashimoto H. PLAG1 expression in mesenchymal tumors: an immunohistochemical study with special emphasis on the pathogenetical distinction between soft tissue myoepithelioma and pleomorphic adenoma of the salivary gland. Pathol Int. 62: 1-7, 2012

・Hisaoka M, Matsuyama A, Nagao Y, Luan L, Kuroda T, Akiyama H, Kondo S, Hashimoto H. Identification of altered microRNA expression patterns in synovial sarcoma. Genes Chromosomes Cancer 50: 137-145, 2011

・Matsuyama A, Hisaoka M, Nagao Y, Hashimoto H. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study. Virchows Arch 458: 583-592, 2011

・ 久岡正典、松山篤二、横山庫一郎、橋本洋. Giant collagen rosetteを伴う低悪性線維粘液性肉腫の1例．診断病理 28: 69-72, 2011

・ 久岡正典、 松山篤二、 中本充洋、 横山庫一郎 . 粘液炎症性線維芽細胞肉腫の1例．診断病理 28: 288-290, 2011

更新日：2023年4月10日
文責：第1病理学